Skip to main content
VIVS
NASDAQ Life Sciences

Stockholders Back Reverse Split, Warrant Repricing, and Equity Plan Expansion at VivoSim

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$0.202
Mkt Cap
$3.349M
52W Low
$0.191
52W High
$3.54
52W Position info
5.5% above low
Off High info
94% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

VIVS is trading near its 52-week low of $0.191 (5.5% above the low) on light trading volume (0.1× avg).

Summary

At the September 30 annual meeting, VivoSim Labs stockholders approved a reverse stock split, a 3.165M share equity plan increase, and warrant-related items, advancing the company's Nasdaq compliance and capital restructuring efforts.


Key Events · Corporate Governance and Compliance · VIVS

  • Reverse Stock Split Approved

    Stockholders approved a reverse split at a ratio of 1-to-5 to 1-to-20, with Board discretion to implement any time on or before September 30, 2027, to regain Nasdaq's $1 minimum bid price compliance.

  • Warrant Exercise Price Reduced

    Stockholders approved reducing the exercise price of May 13, 2024 warrants from $9.60 to $0.85 per share, aligning with the July 2026 private placement terms.

  • 4.7M Shares Authorized for Warrant Exercise

    Stockholders approved the issuance of 4,705,883 shares upon exercise of warrants issued in the July 2026 private placement, a significant potential dilution to existing holders.

  • Equity Plan Increased by 3.165M Shares

    Stockholders approved an amendment to the 2022 Equity Incentive Plan increasing the share reserve by 3,165,000 shares for future equity awards.


Analysis · VIVS · Life Sciences

At the September 30 annual meeting, VivoSim Labs stockholders approved a reverse stock split at a ratio of 1-to-5 to 1-to-20, with the Board retaining discretion to implement it any time before September 30, 2027. The vote also authorized the issuance of 4,705,883 shares upon exercise of July 2026 private placement warrants and reduced the exercise price of May 2024 warrants from $9.60 to $0.85 per share. These approvals are critical for the company's Nasdaq compliance strategy: the reverse split is designed to lift the stock price above the $1 minimum bid requirement, while the warrant repricing and share issuance address the company's capital structure and going concern risk.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, VIVS was trading at $0.20 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.3M. The 52-week trading range was $0.19 to $3.54. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

VIVS - Latest Insights

VIVS
Nov 19, 2026, 8:05 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.1536
Real-time Price: $0.2565 info
Change: +$0.1029 (+67%) info
Market Cap: $5.289M info
VIVS
Nov 12, 2026, 4:06 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.1342
Real-time Price: $0.2565 info
Change: +$0.1223 (+91%) info
Market Cap: $5.289M info
VIVS
Sep 16, 2026, 8:05 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.3067
Real-time Price: $0.2565 info
Change: -$0.0502 (-16%) info
Market Cap: $5.289M info
VIVS
Aug 21, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.286
Real-time Price: $0.2565 info
Change: -$0.0295 (-10%) info
Market Cap: $5.289M info
VIVS
Aug 21, 2026, 4:02 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $0.286
Real-time Price: $0.2565 info
Change: -$0.0295 (-10%) info
Market Cap: $5.289M info